Healthcare Hedge Funds Lead 2025 Gains, But Diversification Remains Critical

Hedge funds delivered positive returns for investors in 2025. Equity long/short strategies emerged as the top performers. Healthcare-focused managers led these gains.

Healthcare Dominates Performance

Equity-focused funds, trading stocks long and short across sectors, geographies, or themes, were the top-performing category through November 2025.

PivotalPath, an industry data provider, reports its Equity Sector Index rose 22.7% year-to-date. This index tracks equity hedge funds across various sectors.

Healthcare-focused equity funds were the standout sub-strategy. They posted a nearly 36% gain between January and November.

Funds targeting Asian equity markets gained 19%. Managers focused on technology, media, and telecommunications stocks rose 17.5%.

Broader Strategy Returns

Event-driven funds, which profit from mispricings related to corporate catalysts, were up 12.1% year-to-date. Multi-strategy managers saw gains of 9.2% over the same period.

PivotalPath’s Global Macro Index, tracking bets on macroeconomic trends, increased 8.6%. The broader Composite Index, measuring 1,100 managers across all strategies, rose 10.8% year-to-date.

Correlation Concerns Persist

Despite positive returns, PivotalPath warns of continued high correlations between hedge funds and broader equity markets. This could surprise investors during a stock market downturn.

Michaël Lok, Group CIO and Co-CEO Asset Management at Union Bancaire Privée, emphasizes diversification. He states diversifying across styles and factors is crucial for portfolio construction and drawdown management.

Why Healthcare Led the Way

Several themes fueled healthcare hedge funds' strong performance. These include the weight-loss drug development race and Medicare price negotiations. Mounting pressure on large pharmaceutical companies facing patent expirations also played a role.

PivotalPath noted healthcare offered hedge funds "clean dispersion" in late 2025. Trial readouts, label expansions, pricing news, and takeover rumors drove clear winners and losers. This created opportunities for idiosyncratic trades.

Rhenman & Partners Asset Management, a healthcare hedge fund, sees further upside. They cite greater political and regulatory clarity. A growing IPO pipeline for 2026 also supports this outlook.

The firm states strong fundamentals, growth outlook, an active deal environment, and attractive valuations underpin a robust setup across the healthcare sector.

Investor Action

You must maintain diversification across strategies and sectors. This approach helps manage potential drawdowns. Consider the ongoing market correlations when building your portfolio.